210 related articles for article (PubMed ID: 1973916)
1. [Chronic heart failure: improvement of the prognosis by therapy?].
Drexler H
Herz; 1990 Jun; 15(3):214-21. PubMed ID: 1973916
[TBL] [Abstract][Full Text] [Related]
2. [Drug therapy of heart failure].
Follath F
Ther Umsch; 1993 Jun; 50(6):425-33. PubMed ID: 8351674
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
Ramahi TM; Lee FA
Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
[TBL] [Abstract][Full Text] [Related]
4. [Trends in pharmacological treatment of congestive heart failure].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
[TBL] [Abstract][Full Text] [Related]
5. [New knowledge on the subject of therapy in cardiac decompensation in the light of large trials].
Camerini F; Perkan A; Sinagra G; Di Lenarda A; Pinamonti B; Zecchin M
Ann Ital Med Int; 1994 Oct; 9 Suppl():68S-77S. PubMed ID: 7857761
[TBL] [Abstract][Full Text] [Related]
6. Physiologic determinants of survival in congestive heart failure. The survival hypothesis: how small uncontrolled studies should influence the design of large-scale clinical trials.
Francis GS
Circulation; 1987 May; 75(5 Pt 2):IV74-9. PubMed ID: 3568319
[TBL] [Abstract][Full Text] [Related]
7. [Vasodilator agents in chronic heart failure: which is the best option?].
Corbalán R; Kunstmann S; Jalil J
Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
[TBL] [Abstract][Full Text] [Related]
8. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
Chow MS
Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
[TBL] [Abstract][Full Text] [Related]
9. A review of heart failure treatment.
Guyatt GH; Devereaux PJ
Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
[TBL] [Abstract][Full Text] [Related]
10. Can pharmacological therapy influence the mortality of chronic congestive heart failure?
Widimský J
Cor Vasa; 1992; 34(1):15-30. PubMed ID: 1288941
[TBL] [Abstract][Full Text] [Related]
11. [Vasodilator agents: the lesson from large clinical trials].
Galiè N; Magelli C; Rapezzi C; Branzi A; Magnani B
Cardiologia; 1993 Dec; 38(12 Suppl 1):221-6. PubMed ID: 8020020
[TBL] [Abstract][Full Text] [Related]
12. Use of beta-blockers in chronic congestive heart failure.
Mahanonda N; Samranthin M; Panyarachun S
J Med Assoc Thai; 2000 Oct; 83(10):1240-7. PubMed ID: 11143491
[TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects of differential drug therapy of chronic heart failure].
Erdmann E; Beuckelmann D; Böhm M; Schwinger HG
Z Kardiol; 1992; 81 Suppl 4():97-103. PubMed ID: 1290310
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy of cardiac insufficiency: status 1995].
Rickenbacher P; Buser P; Osswald S; Pfisterer M
Schweiz Med Wochenschr; 1996 May; 126(21):933-45. PubMed ID: 8693314
[TBL] [Abstract][Full Text] [Related]
15. [Drug treatment of cardiac insufficiency with systolic dysfunction].
Follath F
Praxis (Bern 1994); 1997 Feb; 86(7):254-7. PubMed ID: 9139344
[TBL] [Abstract][Full Text] [Related]
16. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
Dessì-Fulgheri P; Paci MV; Rappelli A
Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
[TBL] [Abstract][Full Text] [Related]
17. [Therapy for heart failure].
Just H
Ther Umsch; 2000 May; 57(5):313-20. PubMed ID: 10859991
[TBL] [Abstract][Full Text] [Related]
18. [Vasodilator therapy in cardiac failure].
Akatsuka N
Nihon Rinsho; 1993 May; 51(5):1276-80. PubMed ID: 8101237
[TBL] [Abstract][Full Text] [Related]
19. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
Cohn JN
Herz; 1991 Sep; 16 Spec No 1():267-71. PubMed ID: 1820292
[TBL] [Abstract][Full Text] [Related]
20. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
Yokota Y
J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
